Aspen Pharmacare Assets & Liabilities Overview 2017-2023 | APNHY
Current and historical assets & liabilities overview for Aspen Pharmacare (APNHY) from 2017 to 2023.
| Aspen Pharmacare Annual Assets & Liabilities Overview (Millions of US $) |
|---|
| Aspen Pharmacare Quarterly Assets & Liabilities Overview (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $5.038B | $2.296B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.482B | 5.59 |
| Dr Reddy's Laboratories (RDY) | India | $12.441B | 19.67 |
| BridgeBio Pharma (BBIO) | United States | $4.656B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.183B | 2.48 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.009B | 13.75 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.646B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.447B | 0.00 |
| Generation Bio (GBIO) | United States | $0.193B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.069B | 0.00 |
| Personalis (PSNL) | United States | $0.064B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.025B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |